{"SPADE_UN_19312": {"Sequence Information": {"Peptide Name": "Fusaricidin A/LI-F04a 8", "Sequence": "XTVAXNA", "Sequence Length": 7, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity.", "Pubmed ID": "22392790", "Reference": "ChemMedChem. 2012;7:871-882", "Author": "Bionda N, Stawikowski M, Stawikowska R, Cudic M, López-Vallejo F, Treitl D, Medina-Franco J, Cudic P", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22392790"}], "SPADE ID": "SPADE_UN_19312", "Similar Sequences": [{"SPADE_ID": "SPADE_N_15064", "Similarity": 1.0, "Sequence": "TVA"}, {"SPADE_ID": "SPADE_UN_19312", "Similarity": 1.0, "Sequence": "TVANA"}, {"SPADE_ID": "SPADE_UN_22437", "Similarity": 1.0, "Sequence": "KRFWPLVPVAINTVA"}], "Hemolytic Activity": "Human erythrocytes:0% Hemolysis=16 µg/ml,Human erythrocytes:30% Hemolysis=64 µg/ml", "Target Organism": "Staphylococcus aureus ATCC 29213(MIC=16µg/ml),Staphylococcus aureus ATCC 33591(MIC=16µg/ml),Staphylococcus aureus ATCC 700699(MIC=16µg/ml),Staphylococcus epidermidis ATCC 27626(MIC=8µg/ml),Streptococcus pyogenes ATCC 19615(MIC=16µg/ml),Escherichia coli K-12 ATCC 29181(no activity data),Klebsiella pneumoniae K6 ATCC 700603(no activity data)"}}}